This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Huntington disease (HD) is caused by CAG repeat expansion in exon 1 of the IT15 gene, which encodes huntingtin protein. The influence of expanded CAG repeats on the age at onset is clear in the case of low and high number of repeats, but the predictive value is weaker in intermediate ranges.1 Therefore, environmental factors, sex, or interacting genes may alter the course of the disease.1 Although a genome scan report did not link the age at onset with BDNF region,2 other studies have shown that huntingtin functions as a positive regulator of BDNF transcription.3 This may explain the decrease in BDNF levels reported in patients with HD.3 Furthermore, BDNF levels modulate the age at onset in transgenic models.4
Recently, the presence of a polymorphism in the BDNF gene leading to a valine (val) to methionine (met) substitution at position 66 in the BDNF prodomain (Val66Met) has been correlated with deleterious5 or beneficial6 effects in several neuropsychiatric diseases. Here we studied the effect of BDNF on the age at onset, analyzing the relationship of the Val66Met polymorphism and CAG repeat number in patients …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Alert Me
Recommended articles
Genetic testing of children at risk for Huntington's disease
Association of CAG Repeat Length in the Huntington Gene With Cognitive Performance in Young Adults
Weight loss in Huntington disease increases with higher CAG repeat number
Clinical manifestations of homozygote allele carriers in Huntington disease